Gene: PURA
Official Full Name: purine rich element binding protein Aprovided by HGNC
Gene Summary: This gene product is a sequence-specific, single-stranded DNA-binding protein. It binds preferentially to the single strand of the purine-rich element termed PUR, which is present at origins of replication and in gene flanking regions in a variety of eukaryotes from yeasts through humans. Thus, it is implicated in the control of both DNA replication and transcription. Deletion of this gene has been associated with myelodysplastic syndrome and acute myelogenous leukemia. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO35782 | PURA Knockout cell line (HeLa) | Human | PURA | 1:3~1:6 | Negative | Online Inquiry |
KO35783 | PURA Knockout cell line (HCT 116) | Human | PURA | 1:2~1:4 | Negative | Online Inquiry |
KO35784 | PURA Knockout cell line (HEK293) | Human | PURA | 1:3~1:6 | Negative | Online Inquiry |
KO35785 | PURA Knockout cell line (A549) | Human | PURA | 1:3~1:4 | Negative | Online Inquiry |
PURA Gene Knockout Cell Lines are genetically modified cell lines specifically engineered to disable the PURA gene, which encodes the purine-rich element-binding protein A. These cell lines serve as crucial tools for studying the effects of PURA deficiency, enabling researchers to investigate its role in cellular functions and disease mechanisms. By providing a model to assess gene function, these cell lines facilitate the examination of downstream signaling pathways and gene expression profiles associated with PURA.
The key mechanism of these knockout cell lines involves the targeted deletion of the PURA gene using CRISPR-Cas9 technology, a powerful gene-editing tool that allows for precise modifications at the genomic level. This highly efficient approach ensures consistent and reproducible knockouts across different experiments, providing a reliable platform for research into neurodevelopmental disorders and other conditions linked to PURA dysregulation.
The scientific importance of PURA Gene Knockout Cell Lines cannot be overstated; they are invaluable in both basic research and clinical settings. These cell lines are essential for elucidating the pathophysiological role of PURA in conditions such as intellectual disabilities and neurodevelopmental disorders. They also hold promise for drug discovery and therapeutic interventions targeting related pathways.
Compared to alternative models, PURA Gene Knockout Cell Lines offer specific advantages, including a reduction in phenotypic variability associated with in vivo models and the ability to perform high-throughput screening. Additionally, researchers benefit from the standardized format of these cell lines, which facilitates easier comparison across studies.
Ultimately, PURA Gene Knockout Cell Lines present significant value to researchers, clinicians, and pharmaceutical companies seeking to advance their understanding of genetic disorders and develop novel therapeutics. Our company stands out in the field of genetic engineering, committed to providing high-quality biological products that empower scientific discovery and innovation.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.